Gisele Dion

Insider Reports History

Location
Fremont, CA
Signature
/s/ Milton H. Werner, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gisele Dion:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cytek Biosciences, Inc. Director Stock Option (right to buy) 30,242 14 Jun 2023 Direct
Inhibikase Therapeutics, Inc. Director Stock Option (right to buy) 30,000 16 Jul 2024 Direct

Insider Reports Filed by Gisele Dion

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IKT Inhibikase Therapeutics, Inc. 16 Jul 2024 1 $0 4 Director 18 Jul 2024, 17:23
IKT Inhibikase Therapeutics, Inc. 30 Jun 2023 1 $0 4 Director 05 Jul 2023, 21:16
CTKB Cytek Biosciences, Inc. 14 Jun 2023 1 $0 4 Director 16 Jun 2023, 18:36
IKT Inhibikase Therapeutics, Inc. 01 Sep 2022 1 $0 4 Director 06 Sep 2022, 17:08
IKT Inhibikase Therapeutics, Inc. 01 Sep 2022 0 $0 3 Director 06 Sep 2022, 17:06
CTKB Cytek Biosciences, Inc. 01 Jun 2022 1 $0 4 Director 03 Jun 2022, 17:36
CTKB Cytek Biosciences, Inc. 22 Jul 2021 1 +$85,000 4 Director 27 Jul 2021, 21:00
CTKB Cytek BioSciences, Inc. 22 Jul 2021 0 $0 3 Director 22 Jul 2021, 21:07